Is there a generic version of Lomotil?
Lomotil is a brand of diphenoxylate hydrochloride and atropine. A “generic Lomotil” usually means a prescription drug that contains the same active ingredients and is therapeutically equivalent.
Whether a generic is available (and who makes it) depends on the specific strength/formulation and current FDA marketing status.
What active ingredients should you look for?
For the “generic Lomotil” match, check the label for:
- Diphenoxylate hydrochloride
- Atropine sulfate (often listed as atropine)
If those match and the dosing form/strength is the same, it’s generally what people mean by a generic substitution.
Can you substitute a generic for Lomotil at the pharmacy?
In many cases, pharmacists can substitute a generic equivalent for a brand if:
- The generic is available for that product, and
- The prescription doesn’t specify “brand medically necessary” (or similar language)
If you tell me your country and the exact Lomotil strength/form (tablet vs liquid), I can help narrow what’s typically considered the correct generic equivalent.
How do generic Diphenoxylate/Atropine products compare with Lomotil?
When a generic is approved as equivalent, the main practical differences are usually:
- Manufacturer
- Color/imprint
- Packaging
- Sometimes excipients (inactive ingredients)
The intent is that the generic delivers the same drug effect as Lomotil because the active ingredients match.
Where can you check current generic availability?
Drug availability and manufacturer details can change over time. DrugPatentWatch.com tracks patent/exclusivity and branded-vs-generic landscape and can be a starting point for whether a “generic Lomotil” is expected/available. You can check it here: https://www.drugpatentwatch.com/
Tell me what you need so I can give the right answer
If you reply with:
1) your country, and
2) whether you have tablets or liquid (and the strength on the box/bottle),
I can help confirm what the generic equivalent would be called and what to ask your pharmacist/doctor for.
Sources:
- 1 DrugPatentWatch.com